Related Experiment Videos
Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients?
B Ostrowsky1, J T Steinberg, B Farr
1Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, United States Department of Health and Human Services, Atlanta, Georgia, USA.
Infection Control and Hospital Epidemiology
|March 10, 2001
Summary
Vancomycin-resistant enterococci (VRE) pose a significant threat in healthcare settings. This session explores the critical question of whether to screen and isolate patients for VRE detection.
Area of Science:
- Infectious Diseases
- Healthcare Epidemiology
- Microbiology
Background:
- Antimicrobial resistance is a growing global health concern.
- Vancomycin-resistant enterococci (VRE) are a notable cause of healthcare-associated infections.
- VRE poses significant challenges in clinical settings.
Purpose of the Study:
- To address the clinical dilemma of detecting and isolating patients colonized or infected with VRE.
- To evaluate the implications of VRE screening and isolation protocols.
Main Methods:
- This "Reality Check" session convened experts to discuss VRE management strategies.
- The focus was on the practical aspects of VRE detection and patient isolation.
Main Results:
- The discussion centered on the benefits and drawbacks of routine VRE screening.
- Considerations included resource allocation, infection control effectiveness, and patient outcomes.
Conclusions:
- The optimal strategy for VRE detection and isolation requires careful consideration of multiple factors.
- Further evaluation is needed to establish evidence-based guidelines for VRE management in healthcare facilities.